Meningococcal Disease
📧 Sign up to get email alerts when something new happens for Meningococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: Understanding the Persistence of Immunity After MenC Vaccines
This trial update reports on the persistence of immunity after meningococcal group C vaccines in healthy individuals. The study, conducted b…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers [Phase 3]
Phase 3 trial evaluating the safety and immune response of the MenACWY-CRM meningococcal conjugate vaccine in healthy toddlers; results comp…
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea [Phase 3]
This Phase 3 trial evaluated the immunogenicity and safety of the MenACWY meningococcal conjugate vaccine in adolescents and adults in Korea…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months [Phase 2]
Phase 2 trial evaluating the immune response to a meningococcal ACWY conjugate vaccine in children aged 40 and 60 months; results were poste…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine [Phase 3]
Phase 3 trial comparing Hib-MenCY-TT vaccine to licensed Hib conjugate vaccine assessing safety and immunogenicity; completed with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine [Phase 2]
Phase 2 dose-ranging study evaluating Hib-MenCY-TT vaccine; completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines [Phase 2]
Phase 2 clinical trial update evaluating Hib-MenCY-TT vaccine compared with licensed Hib and meningococcal serogroup C vaccines; study compl…
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age. [Phase 3]
Phase 3 trial comparing Hib-MenCY-TT vaccine to a licensed Haemophilus influenzae type b conjugate vaccine in children aged 12 to 15 months,…
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB [Phase 3]
Phase 3 trial assessing long-term antibody persistence at 1, 3, and 5 years after a fourth Hib-MenCY-TT dose, compared with ActHIB.
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age [Phase 3]
A Phase 3 trial comparing Hib-MenCY-TT with a licensed Haemophilus influenzae type b conjugate vaccine in infants shows safety data; the stu…
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination [Phase 2]
Phase 2 clinical trial assessing antibody persistence and response to re-vaccination with Menactra or Menomune three years after initial men…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612 [Phase 3]
Phase 3 study by GlaxoSmithKline Biologicals evaluating non-inferiority and immunogenicity of Meningococcal Vaccine 134612 has completed wit…
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac
A completed clinical trial update assessing immunogenicity after two doses of the meningococcal outer membrane vesicle vaccine MenBVac.
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Have to be Vaccinated MenBVac®
A clinical trial evaluated the immune response to Neisseria meningitidis serogroup B vaccine MenBVac in 16 participants; the study has compl…
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children [Phase 3]
Phase 3 trial evaluating immunogenicity, safety, tolerability, and memory priming potential of a Meningococcal C conjugate vaccine in health…
-
CLINICAL_TRIALS trial_result · 2011-10-24Clinical Trial Update: Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents [Phase 2]
A Phase 2 trial evaluating the immunogenicity and safety of several rMenB Plus MenACWY vaccine formulations in adolescents has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY [Phase 2]
A Phase 2 trial assessing how long the immune response lasts and the immune response after a booster dose of the MenACWY meningococcal vacci…
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults [Phase 1, Phase 2]
Phase 1/2 safety and blood collection study of a meningococcal B vaccine (RLP2086) in adults has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults [Phase 2]
Phase 2 study evaluating safety, tolerability, and immunogenicity of three doses of the Novartis Meningococcal B Vaccine in healthy at-risk …
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers [Phase 3]
A Phase 3 safety study evaluating the co-administration of Menactra meningococcal vaccine with other pediatric vaccines in healthy toddlers;…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Correlation Between Cytokines and the Severity of Meningococcal Disease
This completed trial evaluated whether cytokine levels correlate with the severity of meningococcal disease (meningococcemia).
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia [Phase 3]
Phase 3 trial in Saudi Arabia evaluated immunogenicity and safety of the Menactra meningococcal vaccine in adolescents; results were posted …
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC [Phase 3]
This Phase 3 long-term persistence study evaluated a booster dose of GSK's Hib-MenC conjugate vaccine. The trial results were completed and …
-
CLINICAL_TRIALS trial_result · 2010-10-04Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents [Phase 3]
Phase 3 study evaluating the safety and immune response of the Novartis Meningococcal ACWY Conjugate Vaccine in adolescents has completed wi…
-
CLINICAL_TRIALS trial_result · 2007-12-27Clinical Trial Update: Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time [Phase 4]
Phase 4 study assessing the safety and immunogenicity of administering Prevnar (Prevenar) and Meningitec together in healthy participants; t…